| Document |
Document Title |
|
WO/2023/146181A1 |
The present invention provides Chlorella vulgaris H92 (Chlorella vulgaris H92)(KCTC 14843BP) having heme precursor production ability. In addition, the present invention provides a method for preparing a chlorella bacterial body or a foo...
|
|
WO/2023/145921A1 |
The purpose of at least one embodiment of the present invention is to provide a processed onion product that has reduced astringentness and pungency, and enhanced robustness and sweetness, and that can be used as a flavor and the like.ã€...
|
|
WO/2023/146460A1 |
A dairy analogue composition comprising a fat phase, an aqueous phase and an emulsifier, wherein the fat phase comprises interesterified coconut oil and wherein the dairy analogue composition is substantially free of hydrogenated fats an...
|
|
WO/2023/146294A1 |
The present invention relates to a pharmaceutical composition containing a Paeonia lactiflora extract for preventing or treating chronic obstructive pulmonary disease. The Paeonia lactiflora extract of the present invention is non-cytoto...
|
|
WO/2023/142879A1 |
The present invention belongs to the field of microbial strains. Disclosed is use of bacillus coagulans in the preparation of a medicament or a food product for mitigating a decline of body functions caused by hyperglycemia and hyperlipi...
|
|
WO/2023/144416A1 |
The present invention relates to compositions comprising osteopontin (OPN) for the treatment and/or prevention of viral infections in mammals, such as humans, in particular infants, young children and pre-schoolers.
|
|
WO/2023/144174A1 |
The invention provides Streptococcus thermophilus mutants, such as DSM22933, which have improved texturizing properties. The strains have: (i) a mutation in the branched chain amino acid transport ATP-binding protein LivG (TC 3.A.1.4.1) ...
|
|
WO/2023/146932A1 |
Disclosed herein are compositions and methods for forming nutritional compositions comprising genistein. In an embodiment, an orally consumable nutritional supplement comprises a thickening agent, genistein, and a saffron extract, wherei...
|
|
WO/2023/143310A1 |
The present invention belongs to the technical field of biology, and relates to a method for isolating saccharides in pre-hydrolysates of hardwood pulping. The method comprises: using manganese peroxidase to treat a pre-hydrolysate of ha...
|
|
WO/2023/145785A1 |
The problem of the present invention is to provide an agent, a food composition, an animal feed composition, and a drug composition, each containing n-6DPA, administered orally, used for preventing thrombosis, and having an outstanding t...
|
|
WO/2023/144753A2 |
The present disclosure concerns polypeptide having fumonisin esterase activity exhibiting increased fumonisin esterase activity, when measured at a temperature of at least 37°C, when compared to the control polypeptide comprising the am...
|
|
WO/2023/145791A1 |
The purpose of the present invention is to provide a W/O/W emulsion that contains inositol and has excellent stability over time, and a method for producing the W/O/W emulsion. The present invention relates to, inter alia, a W/O/W emulsi...
|
|
WO/2023/146501A1 |
The invention relates to yogurt that can be consumed by lactose intolerant people and has a long shelf life.
|
|
WO/2023/143869A1 |
The object of the present invention is a machine and the continuous cycle processing process for pears, which includes mechanisms for feeding and distributing, housing and holding, aligning and expelling, enucleating the endocarp and pee...
|
|
WO/2023/146274A1 |
The present invention relates to a composition for preventing, alleviating and/or treating alopecia or poliosis (or poliosis circumscripta), and the like, and was accomplished by identifying that an aldehyde dehydrogenase 2 (ALDH2) activ...
|
|
WO/2023/144232A1 |
The present invention relates to an improved apparatus and method for delivering a comestible coating substance and more particularly, though not necessarily, to an improved apparatus for delivering a powder coating to disc-like or disc-...
|
|
WO/2023/146677A1 |
A tuber seed cutter sterilization device is disclosed. The tuber seed cutter is configured to receive a flammable gas and sterilize a tuber seed cutter having a rotational blade and a tuber conveyer, the rotational blade is configured to...
|
|
WO/2023/147518A1 |
The invention relates to a three-dimensional food printing system and method for fabricating porous hydrogel particles having small sizes and high porosity. The inventive method first forms a highly consistent biopolymer solution with de...
|
|
WO/2023/145449A1 |
A carrot processing method comprising: a watering step (S1) for soaking peeled raw carrots (1) in a hypotonic solution; a squeezing step (S2) for compressing/crushing and squeezing the carrots (1) by a cold press juicer; and a cooling st...
|
|
WO/2023/143861A1 |
The present disclosure relates to a method and a system for processing insects or insect larvae. The method comprises a first heating step of heating the insects or insect larvae in a first fluid at a temperature of 40°C to 105°C, a co...
|
|
WO/2023/144148A1 |
The present document relates to a fungi-based fat tissue comprising fungal biomass, fat(s) and water. The present document also discloses methods for producing such fungi-based fat tissue and products comprising it.
|
|
WO/2023/146852A2 |
Disclosed herein are methods and compositions for the production of cell-based meat products with an enhanced uniformity of structure. In particular, the technology of the disclosure relates to filamentous fungus-yeast biocapsules and th...
|
|
WO/2023/147288A1 |
Described herein is a method of acquiring a scaffold for a cultivated meat product comprising: (a) forming hydrogel fibers; (b) crosslinking the hydrogel fibers to obtain crosslinked hydrogel fibers; and (c) lyophilizing the crosslinked ...
|
|
WO/2023/144286A1 |
The present invention provides an encapsulated composition comprising at least one core-shell microcapsule, wherein the at least one core-shell microcapsule comprises a core comprising at least one benefit agent and a shell surrounding t...
|
|
WO/2023/143221A1 |
A composition for preventing or treating osteoporosis, a preparation thereof, and use thereof in preventing or treating osteoporosis. The composition is mainly composed of a GPX4 agonist and a lipoxygenase 15(Alox-15) inhibitor, and coop...
|
|
WO/2023/147496A1 |
A fermentation process for extracting cannabis-based phytocompounds is described. The process utilizes wine or bear yeasts to ferment cannabis flowers, resulting in cannabis lees enriched with cannabis-based phytocompounds.
|
|
WO/2023/146057A1 |
The production method of the present invention enables: tomatoes having enhanced sweetness to be produced while preventing damage to the surface of tomatoes; and leakage of injected stevioside from the produced tomatoes to be reduced so ...
|
|
WO/2023/145832A1 |
The purpose of the present invention is to provide a novel technology for modifying the properties of the heat-coagulated gel of egg white protein. In the present invention, a composition containing soy protein that has been subjected to...
|
|
WO/2023/146544A1 |
The present invention describes methods for the fermentative production of taurine-containing products from unicellular organisms. More particularly, the invention relates to genetic modifications of the taurine and/or substrate biosynth...
|
|
WO/2023/146123A1 |
The present invention relates to a composition for preventing or treating inflammatory diseases comprising a composite extract of Ocimum basilicum, Cirsium nipponicum (Maxim.) Makino, and Aruncus dioicus as an active ingredient. It has b...
|
|
WO/2023/146035A1 |
The present invention relates to a novel antibody binding to prion proteins. According to the present invention, the antibody can bind with high specificity to prion proteins themselves and to cancer cells in which the prion proteins are...
|
|
WO/2023/141408A1 |
A method for promoting muscle regeneration in a subject comprises administering beta-hydroxy beta-methylbutyrate (HMB) and at least one citrus flavonoid to the subject.
|
|
WO/2023/140723A1 |
The present invention relates to novel bacteriophage KMSP1 having the ability to specifically kill Staphylococcus bacteria, an antibiotic composition comprising the bacteriophage, a feed additive composition, a feed, a disinfectant or a ...
|
|
WO/2023/140140A1 |
Disclosed is an oil and fat composition for baked confectionery, which does not contain partially hydrogenated oil and fat, and from which baked confectionery dough having high water absorbability and good texture is obtained. The oil an...
|
|
WO/2023/140524A1 |
The present invention relates to an antifibrotic inhibitory composition, and to: a pharmaceutical composition for preventing or treating liver fibrosis, comprising, as an active ingredient, a peptide derived from a stem cell culture solu...
|
|
WO/2023/139493A1 |
The present invention relates to a method for the production of a muscle and/or adipose tissue, in particular cultured meat, providing the use of engineered cells capable of differentiating in muscle and/or adipose cells in a temperature...
|
|
WO/2023/141658A1 |
Compositions and methods for increasing absorption of nutrients by a body. A composition includes a liposome comprising a lipid bilayer, wherein the liposome comprises an internal core. The composition includes a nutrient payload dispose...
|
|
WO/2023/138777A1 |
The present invention relates to a method for producing hesperetin dihydrochalcone from hesperetin as starting material. Furthermore, the present invention relates to a method for imparting or modifying a sweet taste impression.
|
|
WO/2023/139907A1 |
Provided is a nanoemulsion that is endowed with an antiseptic effect and is stable in environments contaminated with bacteria. The problem addressed by the present invention is solved by a nanoemulsion that has an average particle size o...
|
|
WO/2023/140658A1 |
The present invention relates to a composition for diagnosing sepsis by using brain-derived neurotrophic factor (BDNF) and to a method for detecting a diagnostic marker and, more specifically, to a composition for diagnosing sepsis, comp...
|
|
WO/2023/139278A1 |
The present invention relates to an apparatus and a process for manufacturing a protein product from green leaved biomass such as grass, clover, alfalfa, or the like. Also, the present invention relates to a process for manufacturing pro...
|
|
WO/2023/140407A1 |
The present invention relates to a pharmaceutical composition for preventing or treating sarcopenia. More specifically, by comprising coumestrol or pharmaceutically acceptable salt thereof, muscle strength and endurance can be increased ...
|
|
WO/2023/141202A1 |
This invention is directed to methods for treating and preventing cancer through the administration of a short-chain fatty acid.
|
|
WO/2023/140505A1 |
The present invention relates to a composition for preventing or treating neurodegenerative or motor neuron diseases, containing halofuginone as an active ingredient. Specifically, it was confirmed that, in amyotrophic lateral sclerosis ...
|
|
WO/2023/139443A1 |
The invention relates to a drum cooker for cooking pourabe, floating, and non-floating products, in particularly food or animal feed, said drum cooker also being suitable for blanching or cooling. The drum cooker is to allow a discharge ...
|
|
WO/2023/141558A1 |
The invention relates to the field of plant-based proteins, in particular wheat proteins, used in the aqua feed industry. The invention covers a process for preparing a coarse devitalized wheat gluten composition and the product obtained...
|
|
WO/2023/140602A1 |
The present invention relates to a composition for preventing, ameliorating, or treating inflammatory diseases comprising extracellular vesicles (EVs) derived from Roseburia spp. strains and/or Bifidobacterium spp. strains. The EVs of th...
|
|
WO/2023/140721A1 |
The present invention relates to the diagnosis of immunity reduction through intestinal microflora analysis of stomach cancer patients, and a theragnostic composition using intestinal microflora. It has been identified that novel compoun...
|
|
WO/2023/140565A1 |
The present invention provides a blood sugar lowering composition comprising, as an active ingredient of alpha-glucosidase activity inhibition, a fermentation product obtained by fermenting Carthamus tinctorius L. seed with lactic acid b...
|
|
WO/2023/140236A1 |
This milk component-containing beverage having a total protein content of 3.00 mass% or less enhances milk flavor and milk-like taste. The milk component-containing beverage, which contains milk fat and milk protein and of which the tota...
|
